pharma · Alzheimer's Disease · Type 2 Diabetes Mellitus · VTVT
vTv Therapeutics
vTv Therapeutics is a pharma organization headquartered in High Point, USA. It trades on NYSE under ticker VTVT. Primary therapeutic focus areas include Alzheimer's Disease, Type 2 Diabetes Mellitus, Diabetes Mellitus, T
3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US HQ
55 Employees
Public company Type
VTVT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US
- Employees
- 55
- Programs
- 14
- Drugs
- 2
- Patents
- 50
Cadisegliatin 800 mg QD
Phase 3 · small molecule · Diabetes Mellitus, Type 1
Cadisegliatin 800 mg QD for Diabetes Mellitus, Type 1 is a Phase 3 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code TTP399-302
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- vTv Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Diabetes Mellitus, Type 1
- Status
- active
- Trials
- 1